Skills Alliance
Senior Vice President Regulatory Affairs

How your CV stacks up
Upload your CV to see how well it fits this job role
?%
SVP Regulatory Affairs / Chief Regulatory Affairs Officer
Location: UK, Germany or United States
Confidential search | Late-stage biotechnology
The opportunity
A late-stage biotechnology company developing novel oral therapies for neurological and autoimmune diseases is seeking an accomplished regulatory executive to lead its global regulatory strategy.
With a lead programme in pivotal Phase 3 development and additional clinical and preclinical assets, the company is approaching a significant transition towards registration and potential commercialisation. This leader will shape the path from pivotal data to submission and approval, while guiding regulatory development across the broader pipeline.
The appointment may be made at SVP Regulatory Affairs or Chief Regulatory Affairs Officer level, depending on experience and agreed scope.
Key responsibilities
- Own global regulatory strategy, with immediate emphasis on US registration and a clear European development and approval pathway.
- Lead NDA preparation and submission readiness, aligning clinical, statistical, nonclinical, safety and CMC contributions into a compelling regulatory dossier.
- Serve as the senior regulatory representative with FDA, EMA and other relevant health authorities, leading scientific advice, milestone meetings and submission discussions.
- Guide regulatory strategy for additional indications and pivotal programmes, including trial design, endpoints and evidence requirements.
- Anticipate regulatory risks and translate complex development questions into clear recommendations for executive leadership.
- Partner closely with Clinical Development, Biostatistics, Medical Safety, CMC, Quality and Commercial to support an integrated route to approval.
- Build and lead a proportionate regulatory function, combining internal expertise with specialist external support.
- Oversee submission quality, regulatory operations, labelling strategy and responses to health authority questions.
Reasons to use Rodeo
I’m in my final year doing Economics and I don’t know whether to apply for grad schemes now or do a masters first. What do you think?
Honest answer — it depends on where you want to end up. A lot of top grad schemes (Big 4, civil service, banking) don’t need a masters. Let’s look at the ones you’d be competitive for now, and we can decide if a masters actually adds anything.
Also worth knowing: most autumn 2026 applications are open now. Timing matters more than you think.
Start with a chat, not a search bar
Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.
Graduate Consultant — 2026 Scheme
Why you're a good match
StrongYour economics background and your summer at a regional bank line up with what PwC looks for on the consulting scheme. Applications close in four weeks.
See breakdownIt searches the market for you
Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.
Why you're a good match
You’ve got the grades and the economics background, and your bank internship is exactly the experience this scheme looks for. Apply soon — deadlines close within the month.
Experience fit
Your summer at the bank plus your econometrics coursework map directly to the day-one responsibilities on this scheme — client modelling, market briefings, and deal support.
Only hits
No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.
Candidate profile
- Extensive regulatory affairs experience, including senior leadership within biotechnology or pharmaceutical organisations.
- Direct ownership of an NDA or MAA through submission, review and approval, with substantial FDA engagement.
- Strong expertise in late-stage clinical development and registration strategy; neurology or multiple sclerosis experience is highly desirable.
- Experience with oral small-molecule therapies and the integration of clinical, nonclinical and CMC requirements.
- Proven ability to lead complex health authority negotiations and resolve challenging regulatory questions.
- Comfortable operating strategically while remaining closely involved in submission execution within a lean biotechnology environment.
- Track record of building teams, managing external partners and influencing decisions across executive and development functions.
- Advanced qualification in a relevant scientific, medical or pharmaceutical discipline preferred.


Get help with your application
Your very own career expert that helps elevate your application to the next level.
Why join?
An opportunity to take ownership of the regulatory agenda at a pivotal stage of development, influence the route to potential first approval and establish the foundations for a broader neurological and autoimmune portfolio.
Candidates based in the UK, Germany or United States will be considered, with international travel anticipated.
“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”
Jessica, London
Location